235980 — Medpacto Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩319bn
- KR₩253bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -13,516 | -25,352 | -17,040 | -35,753 | -35,325 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1,523 | -66.5 | -9,472 | 1,085 | 7,784 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4,039 | 600 | -365 | 3,189 | -593 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -15,204 | -23,382 | -25,153 | -29,614 | -26,301 |
Capital Expenditures | -2,677 | -811 | -909 | -925 | -173 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -43,243 | 26,940 | -76,858 | 26,688 | 96,699 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -45,920 | 26,129 | -77,766 | 25,763 | 96,526 |
Financing Cash Flow Items | -350 | -24.4 | 34 | — | -15 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 60,997 | -60.4 | 101,523 | 2,898 | 2,014 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -128 | 2,519 | -1,399 | -933 | 72,244 |